Bioniq is a company that spent years analyzing blood markers to develop its patented algorithm, enabling the company to create 100% personalized supplement formulas based on one of the largest biochemical databases of its kind that spans over five continents. These formulas support your health by optimizing your micronutrient status. Pulse 2.0 interviewed Bioniq founder and CEO Vadim Fedotov to learn more about the company.
Vadim Fedotov’s Background
What is Vadim Fedotov’s background? Fedotov said:
“In the early days, I was a professional basketball player with the German National Team and in the USA. Due to consistent injuries, I shifted careers and dove into the corporate sphere, where I held significant positions as the CEO of various multinational and public companies.”
“In 2019, I co-founded and launched Bioniq in London, UK. Since founding the company, Bioniq has established itself as a leader in the health tech industry, offering personalized supplements based on a comprehensive analysis of blood test data. Through global expansion, we have cultivated one of the most diverse biochemical databases globally, creating tailor-made supplement formulas responsive to individual nutrient deficiencies identified through blood results.”
Formation Of Bioniq
How did the idea for the company come together? Fedotov shared:
“As a former pro athlete, I was always in good physical condition, but years into my corporate roles, fatigue and low energy plagued me without effective advice from my doctors. I realized traditional supplements had a one-size-fits-all approach and didn’t account for individual dosage needs. My journey to address foundational nutrient deficiencies and optimize my health sparked the creation of Bioniq.”
“The current blanket approach to supplementation can lead to deficiencies or a surplus of vitamins and minerals within the body. Seeing this in the market, we knew we needed to create a way for people to ensure they received the right amount of micronutrients based on their unique data.”
Favorite Memory
What has been Fedotov’s favorite memory of working for the company so far? Fedotov reflected:
“On a personal level, I’ve always enjoyed witnessing the growth of our team members who are making significant contributions in the health and wellness space that are now doing this on a global stage.”
“From a company perspective, seeing the accumulation of our progress and achievements reach the leading minds in health and world-leading athletes that are now publicly promoting their affiliation and usage of Bioniq. For example, Cristiano Ronaldo, who has been a Bioniq member since 2022, invested in the company this year, elevating his participation and affiliation with the brand..”
Core Products
What are the company’s core products and features? Fedotov explained:
“We offer two versions of our personalized supplement formulas, PRO and GO”
“Bioniq PRO offers high performers and health enthusiasts the greatest level of personalization and incorporates blood biomarker data into its algorithm, offering users the option to upload existing bloodwork into the system to gain recommendations based upon a global repository of data or book a blood test through Bioniq via a partner lab. Blood biomarker data is then analyzed to assess current nutrient status, identify imbalances, and address them by providing users with a tailor-made daily supplement formula. 1:1 nutrition consultations also allow users to discuss unique needs and next steps with a Registered Dietitian.”
“Bioniq GO utilizes the company’s same proprietary database to offer users a more accessible option, based on a questionnaire that prompts the AI algorithm to recommend users with a unique supplement blend based on their responses and previous users’ blood biomarker data.”
Challenges Faced
What challenges have Fedotov and the team faced in building the company? Fedotov acknowledged:
“From the perspective of the sector, our biggest challenge has been in the time and resources needed to educate the market that supplements should not be a one-size solution. To date, too many people are living with the false sense of security that their off-the-shelf supplements are giving them exactly what they need. Many are unaware that personalized supplements exist and that a product like Bioniq can provide them with a bigger micronutrient impact.”
Evolution Of Bioniq’s Technology
How has the company’s technology evolved since launching? Fedotov noted:
“Our algorithm is constantly evolving and producing more accurate predictions of our member needs for ingredients and dosages to allow our members to optimize at a deeper level based on their body’s needs and goals in a safe but efficient way.”
“We evolved from a single-product company to a multi-product company with the addition of our Bioniq GO option. Bioniq GO allows us to synthesize data from blood test biomarker results shared from our PRO users and utilize our proprietary algorithm to create the highest level of personalized supplement formulas without drawing blood.”
“We are also continually working to update and evolve our algorithm to allow for further accessibility and scalability for the company and our products.”
Significant Milestones
What have been some of the company’s most significant milestones? Fedotov cited:
— Partnering with the leading Medical Wellness Institute Lanserhof within our first year of launching in 2019.”
— In 2021, we entered the UAE / Middle East market and secured ultimate leadership as a brand and thought leader in the region. Additionally, we became an official partner of the government via the Department of Culture and Tourism of Abu Dhabi.”
— In 2022, we expanded into the European market through the acquisition of the leading personalized supplement brand in the German-speaking markets
— In 2023, we launched Bioniq GO in the USA market and significantly grew our market share in the North American region.
— In 2024, we closed our series B round and welcomed global soccer legend Cristiano Ronaldo as a significant investor.
Customer Success Stories
When asking Fedotov about customer success stories, he highlighted:
“You can find a slew of testimonials from our customers HERE.”
Funding
When asking Fedotov about the company’s funding details, he revealed:
“To date, we have raised over $30 million, and Bioniq’s total valuation is $82 million.”
Total Addressable Market
What total addressable market (TAM) size is the company pursuing? Fedotov assessed:
“Bioniq is aiming to address the global supplement market that currently was valued at >$400 billion in 2023 with projections to grow at a CAGR of more than 6%.”
Differentiation From The Competition
What differentiates the company from its competition? Fedotov affirmed:
“With the largest proprietary biochemical database of its kind, Bioniq leverages data from customers across five continents alongside an AI-powered algorithm to assess an individual’s height, weight, age, lifestyle, and health goals to create their tailored, pharmaceutical-grade formulas. Our formulations are Swiss-made and pharmaceutical-grade and use patented prebiotic guar granules for sustained release and precise micro-dosing to address bio-individual micronutrient needs and deficiencies.”
“We are also the only company on the market that analyzes your biochemical data to create and develop a supplement formula that is unique to you.”
Future Company Goals
What are some of the company’s future company goals? Fedotov concluded:
“Our goal is to showcase the benefits of personalized supplementation and prove why they are the better option than what is currently on the market today. The recent funding will allow us to continue our work to expand Bioniq’s availability worldwide and continue our disruption within the supplementation space.”
